Abiopharma

Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors

New Form 8-K - Adicet Bio, Inc. Filed: 2025-07-23 AccNo: 0000950170-25-097881 Size: 304 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Delcath Systems to Host Second Quarter 2025 Earnings Call

Arcturus Therapeutics to Attend Upcoming Investor Conferences

New Form 144 - IQVIA HOLDINGS INC. Filed: 2025-07-23 AccNo: 0001950047-25-005151 Size: 7 KB

Arcutis to Report Second Quarter 2025 Financial Results and Host Conference Call on August 6, 2025

New Form 8-K - Rein Therapeutics, Inc. Filed: 2025-07-23 AccNo: 0001193125-25-163400 Size: 141 KB Item 5.07: Submission of Matters to a Vote of Security Holders

Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update

Oil-Dri Corporation of America Wins 2025 Top Workplaces Industry Award, A National Recognition

New Form 4 - INCYTE CORP Filed: 2025-07-23 AccNo: 0000879169-25-000095 Size: 5 KB

Destiny 2: Latest News and Updates

Best Cross Platform Games: Top Titles for Multiplayer Fun in 2025

Everything To Know About AppleCare One—Apple’s New Device Protection Plan

RXST LEGAL UPDATE: RxSight, Inc. Sued for Fraud Amid Declining LAL Utilization -- Investors with Losses are Notified to Contact BFA Law before September 22 Class Action Deadline

New Form 144 - Twist Bioscience Corp Filed: 2025-07-23 AccNo: 0001959173-25-004708 Size: 7 KB